1. Home
  2. Labeler Index
  3. Sanofi Pasteur Inc.
  4. 49281-190
  5. NDC Package Code: 49281-190-20 Imogam Rabies-ht

NDC Package 49281-190-20 Imogam Rabies-ht

Human Rabies Virus Immune Globulin Injection, Solution Intramuscular - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
49281-190-20
Package Description:
1 VIAL, SINGLE-DOSE in 1 CARTON / 2 mL in 1 VIAL, SINGLE-DOSE (49281-190-58)
Product Code:
49281-190
Proprietary Name:
Imogam Rabies-ht
Non-Proprietary Name:
Human Rabies Virus Immune Globulin
Substance Name:
Human Rabies Virus Immune Globulin
Usage Information:
Rabies Immune Globulin (Human) Heat Treated, Imogam Rabies – HT, in conjunction with the standard series of Rabies Vaccine vaccinations, is indicated for individuals suspected of exposure to rabies, particularly severe exposure, with one exception: persons who have been previously immunized with Rabies Vaccine. Previously immunized persons are those who have had a documented rabies virus neutralizing antibody titer and who have completed one of the recommended regimens (pre-exposure or post-exposure) with a cell culture vaccine or another vaccine. Administer only vaccine to these persons (i.e., post-exposure for a person previously vaccinated). (1)Inject Imogam Rabies – HT, as promptly as possible after exposure, along with the first dose of vaccine. If initiation of treatment is delayed for any reason, still administer Imogam Rabies – HT and the first dose of vaccine, regardless of the interval between exposure and treatment. If Rabies Immune Globulin (Human) was not administered when vaccination was begun (i.e., day 0), it can be administered up to and including day 7 of the post-exposure prophylaxis series. (1)In order to manage potential human exposures to rabies appropriately, the risk of infection must be accurately assessed. Rabies virus is usually transmitted by the bite of a rabid animal (dog, bat, etc.) but can occasionally penetrate abraded skin contaminated with the saliva of infected animals. Progress of the virus after exposure is believed to follow a neural pathway, and the time between exposure and clinical rabies is a function of the proximity of the bite (or abrasion) to the central nervous system and the dose of virus injected. The incubation is usually 2 to 6 weeks but can be longer. After severe bites about the face, neck, and arms, it may be as short as 10 days. After initiation of the vaccine series (human diploid cell origin), it takes approximately one week for development of immunity to rabies; therefore, the value of immediate passive immunization with rabies antibodies in the form of Rabies Immune Globulin (Human) cannot be overemphasized.Recommendations for passive and active immunization after exposure to an animal suspected of having rabies have been outlined by the WHO (3) and by the United States Public Health Service Advisory Committee on Immunization Practices (ACIP). (1)Centers for Disease Control (CDC) recommendations were derived from data on the safety and efficacy of active and passive rabies immunization from both uncontrolled human and animal studies.
11-Digit NDC Billing Format:
49281019020
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1652827 - rabies immune globulin, human 150 UNT/ML in 2 ML Injection
  • RxCUI: 1652827 - 2 ML rabies immune globulin, human 150 UNT/ML Injection
  • RxCUI: 1652827 - rabies immune globulin, human 150 UNT/ML per 2 ML Injection
  • RxCUI: 830477 - Imogam Rabies-HT 150 UNT/ML in 2 ML Injection
  • RxCUI: 830477 - 2 ML rabies immune globulin, human 150 UNT/ML Injection [Imogam]
    • Product Type:
    Plasma Derivative
    Labeler Name:
    Sanofi Pasteur Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
    • Active Ingredient(s):
  • HUMAN RABIES VIRUS IMMUNE GLOBULIN 150 [iU]/mL
    • Sample Package:
    No
    FDA Application Number:
    BLA103932
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    04-27-1984
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 49281-190-20 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    4928101902090376Rabies ig heat treated150 IU2122

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 49281-190-20?

    The NDC Packaged Code 49281-190-20 is assigned to a package of 1 vial, single-dose in 1 carton / 2 ml in 1 vial, single-dose (49281-190-58) of Imogam Rabies-ht, a plasma derivative labeled by Sanofi Pasteur Inc.. The product's dosage form is injection, solution and is administered via intramuscular form.

    Is NDC 49281-190 included in the NDC Directory?

    Yes, Imogam Rabies-ht with product code 49281-190 is active and included in the NDC Directory. The product was first marketed by Sanofi Pasteur Inc. on April 27, 1984 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 49281-190-20?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 49281-190-20?

    The 11-digit format is 49281019020. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-249281-190-205-4-249281-0190-20